Efficacy and Safety of PARP Inhibitors in Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-analyses
CC Tzang, HW Wu, CA Lou, YT Li, YF Kang… - Critical Reviews in …, 2025 - Elsevier
Prostate cancer is a significant cause of cancer-related deaths in men. Poly (ADP-ribose)
polymerase inhibitors (PARPi) have been shown to improve progression-free survival …
polymerase inhibitors (PARPi) have been shown to improve progression-free survival …
Hormones as a double-edged sword: the role of hormones in cancer progression and the potential of targeted hormone therapies
D Joshi, J Patel, M Munshi, Z Mistry, A Prajapati… - Medical Oncology, 2024 - Springer
Cancer remains a significant cause of mortality in the world, with increasing prevalence
worldwide. There are numerous treatments ranging from surgery to chemotherapy and …
worldwide. There are numerous treatments ranging from surgery to chemotherapy and …
Olaparib As Therapy For Metastatic-Castration Resistant Prostate Cancer: Systematic Review And Meta Analysis
IMRP Gunawan, F Herawati… - Jurnal Farmasi Sains …, 2024 - journal.ukwms.ac.id
Prostate cancer is the second most prevalent cancer in men with approximately 1.4 million
men worldwide. The main therapy for prostate cancer is androgen deprivation therapy …
men worldwide. The main therapy for prostate cancer is androgen deprivation therapy …